Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Gynecology

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 143 articles:
HTML format



Single Articles


    July 2021
  1. MIX JM, Saraiya M, Thompson TD, Querec TD, et al
    Prevalence of human papillomavirus genotypes in high-grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States.
    Cancer. 2021 Jul 21. doi: 10.1002/cncr.33582.
    PubMed     Abstract available


  2. NYAKUDARIKA NC, Holschneider CH, Sinno AK
    Universal social needs assessment in gynecologic oncology: An important step toward more informed and targeted care in the public safety net.
    Cancer. 2021 Jul 12. doi: 10.1002/cncr.33761.
    PubMed     Abstract available


    June 2021
  3. PRINTZ C
    Some patients with postmenopausal breast cancer can avoid adjuvant chemotherapy: Data indicate that some postmenopausal women with breast cancer can safely skip adjuvant chemotherapy.
    Cancer. 2021;127:1951-1952.
    PubMed    


    May 2021
  4. KIM SR, Tone A, Kim RH, Cesari M, et al
    Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer.
    Cancer. 2021 May 13. doi: 10.1002/cncr.33625.
    PubMed     Abstract available


  5. GARCIA-SOTO AE, McKenzie ND, Whicker ME, Pearson JM, et al
    Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer.
    Cancer. 2021 May 1. doi: 10.1002/cncr.33449.
    PubMed     Abstract available


    April 2021
  6. BUTLER SS, Mahal BA, Moslehi JJ, Nohria A, et al
    Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Controlled Trial.
    Cancer. 2021 Apr 27. doi: 10.1002/cncr.33486.
    PubMed     Abstract available


  7. CHEN YS, Zhou ZN, Glynn SM, Frey MK, et al
    Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the coronavirus disease 2019 (COVID-19) pandemic among low-income women in New York City.
    Cancer. 2021 Apr 26. doi: 10.1002/cncr.33537.
    PubMed     Abstract available


  8. URICK ME, Yu EJ, Bell DW
    High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels.
    Cancer. 2021 Apr 19. doi: 10.1002/cncr.33567.
    PubMed     Abstract available


  9. PRINTZ C
    Lower Cervical Cancer Risk Associated With HPV Vaccine.
    Cancer. 2021;127:1171.
    PubMed    


  10. TAIT SD, Ren Y, Horton CC, Oshima SM, et al
    Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.
    Cancer. 2021 Apr 7. doi: 10.1002/cncr.33473.
    PubMed     Abstract available


  11. MCALPINE JN, Chiu DS, Nout RA, Church DN, et al
    Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis.
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33516.
    PubMed     Abstract available


    March 2021
  12. LEE CK, Friedlander ML, Tjokrowidjaja A, Ledermann JA, et al
    Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis.
    Cancer. 2021 Mar 19. doi: 10.1002/cncr.33517.
    PubMed     Abstract available


  13. RODRIGUEZ VE, LeBron AMW, Chang J, Bristow RE, et al
    Guideline-adherent treatment, sociodemographic disparities, and cause-specific survival for endometrial carcinomas.
    Cancer. 2021 Mar 15. doi: 10.1002/cncr.33502.
    PubMed     Abstract available


    February 2021
  14. MULLINS MA, Ruterbusch JJ, Clarke P, Uppal S, et al
    Trends and racial disparities in aggressive end-of-life care for a national sample of women with ovarian cancer.
    Cancer. 2021 Feb 25. doi: 10.1002/cncr.33488.
    PubMed     Abstract available


  15. MUKAMA T, Kharazmi E, Sundquist K, Sundquist J, et al
    Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study.
    Cancer. 2021 Feb 23. doi: 10.1002/cncr.33456.
    PubMed     Abstract available


    January 2021
  16. SELLA T, Partridge AH
    A new look at old problems: Ovarian function suppression in the real world.
    Cancer. 2021 Jan 28. doi: 10.1002/cncr.33368.
    PubMed    


  17. REEDER-HAYES KE, Mayer SE, Lund JL
    Adherence to endocrine therapy including ovarian suppression: A large observational cohort study of US women with early breast cancer.
    Cancer. 2021 Jan 28. doi: 10.1002/cncr.33367.
    PubMed     Abstract available


  18. MELIN JM, Seppanen VI, Ylostalo TM, Malila NK, et al
    Risk of induced abortions in childhood cancer survivors.
    Cancer. 2021 Jan 25. doi: 10.1002/cncr.33384.
    PubMed     Abstract available


  19. YUAN Y, Pan K, Mortimer J, Chlebowski RT, et al
    Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative.
    Cancer. 2021 Jan 21. doi: 10.1002/cncr.33407.
    PubMed     Abstract available


    December 2020
  20. LARA OD, Smith MJ, Wang Y, O'Cearbhaill R, et al
    Racial disparities in patients with coronavirus disease 2019 infection and gynecologic malignancy.
    Cancer. 2020 Dec 9. doi: 10.1002/cncr.33335.
    PubMed     Abstract available


  21. PRINTZ C
    Screening entire populations for breast and ovarian cancer could prevent millions of cases worldwide, study says.
    Cancer. 2020;126:5007.
    PubMed    


  22. POORVU PD, Gelber SI, Zheng Y, Ruddy KJ, et al
    Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer.
    Cancer. 2020 Dec 1. doi: 10.1002/cncr.33342.
    PubMed     Abstract available


    September 2020
  23. GHIRARDI V, Ronsini C, Trozzi R, Di Ilio C, et al
    Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience.
    Cancer. 2020 Sep 15. doi: 10.1002/cncr.33167.
    PubMed     Abstract available


  24. DUSKA LR, Scalici JM, Temkin SM, Schwarz JK, et al
    Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer.
    Cancer. 2020 Sep 10. doi: 10.1002/cncr.33136.
    PubMed     Abstract available


  25. DESSOURCES K, Hari A, Pineda E, Amneus MW, et al
    Socially determined cervical cancer care navigation: An effective step toward health care equity and care optimization.
    Cancer. 2020 Sep 5. doi: 10.1002/cncr.33124.
    PubMed     Abstract available


    August 2020
  26. KIM SR, Tone A, Kim RH, Cesari M, et al
    Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer.
    Cancer. 2020 Aug 18. doi: 10.1002/cncr.33144.
    PubMed     Abstract available


  27. GATTI A, Haruyama R, Elit L, Howard SC, et al
    How to reduce the impact of cervical cancer worldwide: Gaps and priority areas identified through the essential cancer and primary care packages: An analysis of effective interventions.
    Cancer. 2020 Aug 11. doi: 10.1002/cncr.33116.
    PubMed     Abstract available


  28. KIM EY, Chang Y, Ahn J, Yun JS, et al
    Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women.
    Cancer. 2020 Aug 7. doi: 10.1002/cncr.33138.
    PubMed     Abstract available


  29. PRINTZ C
    Experts say that cervical cancer could be eliminated worldwide with screening, human papillomavirus vaccine.
    Cancer. 2020;126:3387.
    PubMed    


    July 2020
  30. LARA OD, O'Cearbhaill RE, Smith MJ, Sutter ME, et al
    COVID-19 outcomes of patients with gynecologic cancer in New York City.
    Cancer. 2020 Jul 30. doi: 10.1002/cncr.33084.
    PubMed     Abstract available


  31. CORR BR, Moroney M, Sheeder J, Eckhardt SG, et al
    Survival and clinical outcomes of patients with ovarian cancer who were treated on phase 1 clinical trials.
    Cancer. 2020 Jul 22. doi: 10.1002/cncr.33073.
    PubMed     Abstract available


  32. LUTGENDORF SK, Penedo F, Goodheart MJ, Dahmoush L, et al
    Epithelial-mesenchymal transition polarization in ovarian carcinomas from patients with high social isolation.
    Cancer. 2020 Jul 21. doi: 10.1002/cncr.33060.
    PubMed     Abstract available


  33. SRIVASTAVA AJ, Contreras JA, Davis M, Markovina ST, et al
    Early posttherapy clearance of human papillomavirus and treatment response in cervical carcinoma.
    Cancer. 2020 Jul 8. doi: 10.1002/cncr.33040.
    PubMed     Abstract available


    June 2020
  34. PAN K, Chlebowski RT, Mortimer JE, Gunther MJ, et al
    Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative.
    Cancer. 2020 Jun 12. doi: 10.1002/cncr.33002.
    PubMed     Abstract available


  35. BLESSING AM, Santiago-O'Farrill JM, Mao W, Pang L, et al
    Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition.
    Cancer. 2020 Jun 2. doi: 10.1002/cncr.32985.
    PubMed     Abstract available


  36. WESTRICK AC, Bailey ZD, Schlumbrecht M, Hlaing WM, et al
    Residential segregation and overall survival of women with epithelial ovarian cancer.
    Cancer. 2020 Jun 2. doi: 10.1002/cncr.32989.
    PubMed     Abstract available


    May 2020
  37. POORT H, de Rooij BH, Uno H, Weng S, et al
    Patterns and predictors of cancer-related fatigue in ovarian and endometrial cancers: 1-year longitudinal study.
    Cancer. 2020 May 21. doi: 10.1002/cncr.32927.
    PubMed     Abstract available


  38. PRINTZ C
    Research teams unite to develop an early detection test for ovarian cancer.
    Cancer. 2020;126:2113.
    PubMed    


    April 2020
  39. RODRIGUEZ AM, Zeybek B, Vaughn M, Westra J, et al
    Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study.
    Cancer. 2020;126:1656-1667.
    PubMed     Abstract available



  40. The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms.
    Cancer. 2020 Apr 13. doi: 10.1002/cncr.32867.
    PubMed     Abstract available


    March 2020
  41. CHLEBOWSKI RT, Aragaki AK, Anderson GL, Prentice RL, et al
    Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women.
    Cancer. 2020 Mar 25. doi: 10.1002/cncr.32846.
    PubMed     Abstract available


  42. RUSSO M, Newell JM, Budurlean L, Houser KR, et al
    Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma.
    Cancer. 2020 Mar 18. doi: 10.1002/cncr.32822.
    PubMed     Abstract available


  43. SALCEDO MP, Sood AK, Jhingran A, Eifel PJ, et al
    Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women.
    Cancer. 2020 Mar 3. doi: 10.1002/cncr.32807.
    PubMed     Abstract available


    February 2020
  44. LEE YC, Wang L, Kohn EC, Rubinstein L, et al
    Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancer.
    Cancer. 2020 Feb 25. doi: 10.1002/cncr.32783.
    PubMed     Abstract available


  45. PETERSON LL, Park S, Park Y, Colditz GA, et al
    Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study.
    Cancer. 2020 Feb 25. doi: 10.1002/cncr.32798.
    PubMed     Abstract available


  46. PRINTZ C
    Study finds that women with posttraumatic stress disorder have an increased risk of ovarian cancer.
    Cancer. 2020;126:468-469.
    PubMed    


  47. PRINTZ C
    Low-income, Asian American women benefit from human papillomavirus self-sampling tests.
    Cancer. 2020;126:469.
    PubMed    


  48. VYSOTSKAIA V, Kaseniit KE, Bucheit L, Ready K, et al
    Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.
    Cancer. 2020;126:549-558.
    PubMed     Abstract available


    January 2020
  49. KROENKE CH, Paskett ED, Cene CW, Caan BJ, et al
    Prediagnosis social support, social integration, living status, and colorectal cancer mortality in postmenopausal women from the women's health initiative.
    Cancer. 2020 Jan 23. doi: 10.1002/cncr.32710.
    PubMed     Abstract available


  50. PRINTZ C
    Psychological stress is associated with a higher risk of cervical cancer mortality.
    Cancer. 2020;126:240-241.
    PubMed    


  51. GUO F, Scholl M, Fuchs EL, Berenson AB, et al
    BRCA testing in unaffected young women in the United States, 2006-2017.
    Cancer. 2020;126:337-343.
    PubMed     Abstract available


    December 2019
  52. RUBINSTEIN MM, Hyman DM, Caird I, Won H, et al
    Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway.
    Cancer. 2019 Dec 27. doi: 10.1002/cncr.32677.
    PubMed     Abstract available


  53. VERGOTE I, Harter P, Chiva L
    Hyperthermic intraperitoneal chemotherapy does not improve survival in advanced ovarian cancer.
    Cancer. 2019;125 Suppl 24:4594-4597.
    PubMed     Abstract available


  54. BOOKMAN MA
    Can we predict who lives long with ovarian cancer?
    Cancer. 2019;125 Suppl 24:4578-4581.
    PubMed     Abstract available


  55. AREND R, Martinez A, Szul T, Birrer MJ, et al
    Biomarkers in ovarian cancer: To be or not to be.
    Cancer. 2019;125 Suppl 24:4563-4572.
    PubMed     Abstract available


  56. LEE JM, Minasian L, Kohn EC
    New strategies in ovarian cancer treatment.
    Cancer. 2019;125 Suppl 24:4623-4629.
    PubMed     Abstract available


  57. SEHOULI J, Grabowski JP
    Surgery in recurrent ovarian cancer.
    Cancer. 2019;125 Suppl 24:4598-4601.
    PubMed     Abstract available


  58. PIGNATA S, Pisano C, Di Napoli M, Cecere SC, et al
    Treatment of recurrent epithelial ovarian cancer.
    Cancer. 2019;125 Suppl 24:4609-4615.
    PubMed     Abstract available


  59. FUJIWARA K, Hasegawa K, Nagao S
    Landscape of systemic therapy for ovarian cancer in 2019: Primary therapy.
    Cancer. 2019;125 Suppl 24:4582-4586.
    PubMed     Abstract available


  60. KOOLE SN, van Driel WJ, Sonke GS
    Hyperthermic intraperitoneal chemotherapy for ovarian cancer: The heat is on.
    Cancer. 2019;125 Suppl 24:4587-4593.
    PubMed     Abstract available


  61. FRIEDLANDER ML
    Do all patients with recurrent ovarian cancer need systemic therapy?
    Cancer. 2019;125 Suppl 24:4602-4608.
    PubMed     Abstract available


  62. GONZALEZ-MARTIN A, Sanchez-Lorenzo L
    Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: Still promising?
    Cancer. 2019;125 Suppl 24:4616-4622.
    PubMed     Abstract available


  63. HARTER P, Heitz F, Ataseven B, Schneider S, et al
    How to manage lymph nodes in ovarian cancer.
    Cancer. 2019;125 Suppl 24:4573-4577.
    PubMed     Abstract available


    November 2019
  64. CRAFTON SM, Cohn DE, Llamocca EN, Louden E, et al
    Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries.
    Cancer. 2019 Nov 27. doi: 10.1002/cncr.32620.
    PubMed     Abstract available


  65. YANG WL, Lu Z, Guo J, Fellman BM, et al
    Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer.
    Cancer. 2019 Nov 12. doi: 10.1002/cncr.32582.
    PubMed     Abstract available


  66. SANTIAGO-O'FARRILL JM, Weroha SJ, Hou X, Oberg AL, et al
    Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models.
    Cancer. 2019 Nov 12. doi: 10.1002/cncr.32600.
    PubMed     Abstract available


  67. HUNG P, Deng S, Zahnd WE, Adams SA, et al
    Geographic disparities in residential proximity to colorectal and cervical cancer care providers.
    Cancer. 2019 Nov 8. doi: 10.1002/cncr.32594.
    PubMed     Abstract available


  68. PRINTZ C
    Survey of US gynecologic oncologists finds that approximately 64% have experienced sexual harassment.
    Cancer. 2019;125:3691.
    PubMed    


    October 2019
  69. PRINTZ C
    Rethinking a common surgery technique for early cervical cancer: Experts are reconsidering the use of minimally invasive radical hysterectomy as a treatment for early cervical cancer after multiple studies found that patients who undergo the procedure
    Cancer. 2019;125:3485-3487.
    PubMed    


  70. PRINTZ C
    Cervical cancer subtype less detectable by Papanicolaou testing.
    Cancer. 2019;125:3287.
    PubMed    


    September 2019
  71. FICHT AL, Lapidos-Salaiz I, Phelps BR
    Eliminating cervical cancer: Promising developments in primary prevention.
    Cancer. 2019 Sep 26. doi: 10.1002/cncr.32507.
    PubMed    


    August 2019
  72. HAVRILESKY LJ, Yang JC, Lee PS, Secord AA, et al
    Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer.
    Cancer. 2019 Aug 27. doi: 10.1002/cncr.32447.
    PubMed     Abstract available


  73. MULLINS MA, Peres LC, Alberg AJ, Bandera EV, et al
    Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study.
    Cancer. 2019 Aug 15. doi: 10.1002/cncr.32451.
    PubMed     Abstract available


    July 2019
  74. PRINTZ C
    HPV infections most often linked to cervical cancer have declined.
    Cancer. 2019;125:2336-2337.
    PubMed    


    June 2019
  75. STEWART KI, Chasen B, Erwin W, Fleming N, et al
    Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.
    Cancer. 2019 Jun 21. doi: 10.1002/cncr.32329.
    PubMed     Abstract available


  76. HOLLIS RL, Churchman M, Michie CO, Rye T, et al
    High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum.
    Cancer. 2019 Jun 2. doi: 10.1002/cncr.32079.
    PubMed     Abstract available


  77. KONDRASHOVA O, Scott CL
    Clarifying the role of EMSY in DNA repair in ovarian cancer.
    Cancer. 2019 Jun 2. doi: 10.1002/cncr.32135.
    PubMed    


    May 2019
  78. KAHN RM, Gordhandas S, Maddy BP, Baltich Nelson B, et al
    Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
    Cancer. 2019 May 31. doi: 10.1002/cncr.32203.
    PubMed     Abstract available


  79. WASSERMANN J, Gelber SI, Rosenberg SM, Ruddy KJ, et al
    Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer.
    Cancer. 2019 May 23. doi: 10.1002/cncr.32192.
    PubMed     Abstract available


  80. PRINTZ C
    Cervical cancer self-sampling tests could improve access.
    Cancer. 2019;125:1583.
    PubMed    


  81. PRINTZ C
    Culturally tailored intervention increases HPV vaccination rates among Asian American adolescents.
    Cancer. 2019;125:1583.
    PubMed    


  82. PINSKY PF, Black A, Daugherty SE, Hoover R, et al
    Metastatic prostate cancer at diagnosis and through progression in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Cancer. 2019 May 8. doi: 10.1002/cncr.32176.
    PubMed     Abstract available


    April 2019
  83. TSUI J, DeLia D, Stroup AM, Nova J, et al
    Association of Medicaid enrollee characteristics and primary care utilization with cancer outcomes for the period spanning Medicaid expansion in New Jersey.
    Cancer. 2019;125:1330-1340.
    PubMed     Abstract available


  84. LI K, Li Q, Song L, Wang D, et al
    The distribution and prevalence of human papillomavirus in women in mainland China.
    Cancer. 2019;125:1030-1037.
    PubMed     Abstract available


    March 2019
  85. KURNIT KC, Westin SN, Coleman RL
    Microsatellite instability in endometrial cancer: New purpose for an old test.
    Cancer. 2019 Mar 26. doi: 10.1002/cncr.32058.
    PubMed    


  86. BAST RC JR, Matulonis UA, Sood AK, Ahmed AA, et al
    Critical Questions in Ovarian Cancer Research and Treatment: Report of an American Association for Cancer Research Special Conference.
    Cancer. 2019 Mar 5. doi: 10.1002/cncr.32004.
    PubMed     Abstract available


  87. DE ROOIJ BH, Ezendam NPM, Vos MC, Pijnenborg JMA, et al
    Patients' information coping styles influence the benefit of a survivorship care plan in the ROGY Care Trial: New insights for tailored delivery.
    Cancer. 2019;125:788-797.
    PubMed     Abstract available


    February 2019
  88. GROVER S, MacDuffie EC, Wang Q, Bvochora-Nsingo M, et al
    HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana.
    Cancer. 2019 Feb 25. doi: 10.1002/cncr.31972.
    PubMed     Abstract available


  89. LITTLE RF
    Tearing down the false walls to HIV cancer care.
    Cancer. 2019 Feb 25. doi: 10.1002/cncr.31974.
    PubMed    


    January 2019
  90. FROBERG M, Ostensson E, Belkic K, Ostrbenk A, et al
    Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
    Cancer. 2019;125:239-248.
    PubMed     Abstract available


  91. DING DC, Chen W, Wang JH, Lin SZ, et al
    Thyroid cancer risk in women with infertility and association with fertility medications in Taiwan.
    Cancer. 2019 Jan 15. doi: 10.1002/cncr.31964.
    PubMed     Abstract available


  92. MAO W, Peters HL, Sutton MN, Orozco AF, et al
    The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts.
    Cancer. 2019 Jan 8. doi: 10.1002/cncr.31935.
    PubMed     Abstract available


    December 2018
  93. TEMKIN SM, Mallen A, Bellavance E, Rubinsak L, et al
    The role of menopausal hormone therapy in women with or at risk of ovarian and breast cancers: Misconceptions and current directions.
    Cancer. 2018 Dec 20. doi: 10.1002/cncr.31911.
    PubMed     Abstract available


  94. ESKANDER RN
    Mismatch repair in endometrioid endometrial cancer: Increasing our therapeutic proficiency by capitalizing on molecular deficiency.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31902.
    PubMed    


  95. BACKES FJ, Haag J, Cosgrove CM, Suarez A, et al
    Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31901.
    PubMed     Abstract available


  96. PRINTZ C
    High-risk human papillomavirus test a good option for cervical cancer screening.
    Cancer. 2018;124:4591.
    PubMed    


  97. PRINTZ C
    Human papillomavirus testing may detect cervical precancer better than Papanicolaou testing.
    Cancer. 2018;124:4430-4431.
    PubMed    


    November 2018
  98. BINES J, Tevaarwerk AJ
    Baby steps: Pregnancy outcomes after human epidermal growth factor receptor 2-targeted therapy.
    Cancer. 2018 Nov 30. doi: 10.1002/cncr.31878.
    PubMed    


  99. LAITMAN Y, Michaelson-Cohen R, Levi E, Chen-Shtoyerman R, et al
    Uterine cancer in Jewish Israeli BRCA1/BRCA2 mutation carriers.
    Cancer. 2018 Nov 29. doi: 10.1002/cncr.31842.
    PubMed     Abstract available


  100. FREY MK, Kopparam RV, Ni Zhou Z, Fields JC, et al
    Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
    Cancer. 2018 Nov 27. doi: 10.1002/cncr.31856.
    PubMed     Abstract available


  101. AHVENAINEN TV, Makinen NM, von Nandelstadh P, Vahteristo MEA, et al
    Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.
    Cancer. 2018 Nov 13. doi: 10.1002/cncr.31754.
    PubMed     Abstract available


  102. SMITH HJ, McCaw TR, Londono AI, Katre AA, et al
    The antitumor effects of entinostat in ovarian cancer require adaptive immunity.
    Cancer. 2018 Nov 13. doi: 10.1002/cncr.31761.
    PubMed     Abstract available


  103. HARTNETT KP, Mertens AC, Kramer MR, Lash TL, et al
    Pregnancy after cancer: Does timing of conception affect infant health?
    Cancer. 2018 Nov 7. doi: 10.1002/cncr.31732.
    PubMed     Abstract available


  104. PARTRIDGE AH
    Pregnancy after cancer: Timing is everything.
    Cancer. 2018 Nov 7. doi: 10.1002/cncr.31730.
    PubMed    


  105. MAILHOT VEGA RB, Balogun OD, Ishaq OF, Bray F, et al
    Estimating child mortality associated with maternal mortality from breast and cervical cancer.
    Cancer. 2018 Nov 1. doi: 10.1002/cncr.31780.
    PubMed     Abstract available


    October 2018
  106. ORTIZ AP, Engels EA, Nogueras-Gonzalez GM, Colon-Lopez V, et al
    Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected hispanics living in the United States.
    Cancer. 2018 Oct 22. doi: 10.1002/cncr.31702.
    PubMed     Abstract available


  107. LAMBERTINI M, Martel S, Campbell C, Guillaume S, et al
    Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.
    Cancer. 2018 Oct 18. doi: 10.1002/cncr.31784.
    PubMed     Abstract available


  108. HOSKINS KF, Tejeda S, Vijayasiri G, Chukwudozie IB, et al
    A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.
    Cancer. 2018 Oct 15. doi: 10.1002/cncr.31635.
    PubMed     Abstract available


  109. CHLEBOWSKI RT, Luo J, Anderson GL, Barrington W, et al
    Weight loss and breast cancer incidence in postmenopausal women.
    Cancer. 2018 Oct 8. doi: 10.1002/cncr.31687.
    PubMed     Abstract available


    September 2018

  110. Survivors of endometrial cancer are more likely to experience cardiovascular problems.
    Cancer. 2018;124:3633.
    PubMed    


    June 2018
  111. ARMER JS, Clevenger L, Davis LZ, Cuneo M, et al
    Life stress as a risk factor for sustained anxiety and cortisol dysregulation during the first year of survivorship in ovarian cancer.
    Cancer. 2018 Jun 15. doi: 10.1002/cncr.31570.
    PubMed     Abstract available


    May 2018
  112. DUSKA LR
    Access to quality gynecologic oncology care: A work in progress.
    Cancer. 2018 May 16. doi: 10.1002/cncr.31391.
    PubMed    


  113. SHALOWITZ DI, Huh WK
    Access to gynecologic oncology care and the network adequacy standard.
    Cancer. 2018 May 16. doi: 10.1002/cncr.31392.
    PubMed    


  114. ADAR T, Rodgers LH, Shannon KM, Yoshida M, et al
    Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.
    Cancer. 2018 May 11. doi: 10.1002/cncr.31534.
    PubMed     Abstract available


    March 2018

  115. Erratum: Pashankar F, Hale JP, Dang H, et al. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative. Cancer. 2016;122:230-237.
    Cancer. 2018;124:1302.
    PubMed    


  116. EL-JAWAHRI A, Fishman SR, Vanderklish J, Dizon DS, et al
    Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation.
    Cancer. 2018 Mar 14. doi: 10.1002/cncr.31333.
    PubMed     Abstract available


    February 2018
  117. IYER NS, Cartmel B, Friedman L, Li F, et al
    Lymphedema in ovarian cancer survivors: Assessing diagnostic methods and the effects of physical activity.
    Cancer. 2018 Feb 13. doi: 10.1002/cncr.31239.
    PubMed     Abstract available


  118. PRINTZ C
    Abdominal fat linked to cancer risk in postmenopausal women.
    Cancer. 2018;124:449.
    PubMed    


    January 2018
  119. LEVINE JM, Whitton JA, Ginsberg JP, Green DM, et al
    Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31121.
    PubMed     Abstract available


  120. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    PubMed     Abstract available


    December 2017
  121. STEWART SL, Harewood R, Matz M, Rim SH, et al
    Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5138-5159.
    PubMed     Abstract available


  122. BENARD VB, Watson M, Saraiya M, Harewood R, et al
    Cervical cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5119-5137.
    PubMed     Abstract available


  123. PRINTZ C
    Women who undergo HPV testing receive earlier detection and treatment of cervical precancers.
    Cancer. 2017;123:4751.
    PubMed    


  124. TAARNHOJ GA, Christensen IJ, Lajer H, Fuglsang K, et al
    Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study.
    Cancer. 2017 Dec 6. doi: 10.1002/cncr.31165.
    PubMed     Abstract available


  125. GROEN R, Abe K, Yoon HS, Li Z, et al
    Application of microscope-based scanning software (Panoptiq) for the interpretation of cervicovaginal cytology specimens.
    Cancer. 2017;125:918-925.
    PubMed     Abstract available


    November 2017
  126. PRINTZ C
    Large population study quantifies chances of pregnancy after cancer treatment.
    Cancer. 2017;123:4308.
    PubMed    


  127. LUTGENDORF SK, Thaker PH, Arevalo JM, Goodheart MJ, et al
    Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31078.
    PubMed     Abstract available


    October 2017
  128. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
    Psychological distress associated with cancer screening: A systematic review.
    Cancer. 2017;123:3882-3894.
    PubMed     Abstract available


  129. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    PubMed     Abstract available


    September 2017
  130. LE GALLO M, Rudd ML, Urick ME, Hansen NF, et al
    The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.
    Cancer. 2017 Sep 21. doi: 10.1002/cncr.30971.
    PubMed     Abstract available


  131. PRINJA S, Bahuguna P, Faujdar DS, Jyani G, et al
    Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program.
    Cancer. 2017;123:3253-3260.
    PubMed     Abstract available


    August 2017
  132. TRACHT JM, Davis AD, Fasciano DN, Eltoum IA, et al
    Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?
    Cancer. 2017 Aug 17. doi: 10.1002/cncy.21905.
    PubMed     Abstract available


  133. MOORE KN, Borghaei H, O'Malley DM, Jeong W, et al
    Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor alpha-targeting antibody-drug conjugate, in patients with solid tumors.
    Cancer. 2017;123:3080-3087.
    PubMed     Abstract available


  134. HUNG YP, Lovitch SB, Qian X
    Histiocytic sarcoma: New insights into FNA cytomorphology and molecular characteristics.
    Cancer. 2017;125:604-614.
    PubMed     Abstract available


    July 2017
  135. PRINTZ C
    Expert panel issues new global cervical cancer screening guideline.
    Cancer. 2017;123:2387-2388.
    PubMed    


    June 2017
  136. GE Y, Christensen P, Luna E, Armylagos D, et al
    Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
    Cancer. 2017 Jun 2. doi: 10.1002/cncy.21875.
    PubMed     Abstract available


    May 2017
  137. GUO M, Khanna A, Wang J, Dawlett MA, et al
    Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Cancer. 2017 May 12. doi: 10.1002/cncy.21877.
    PubMed     Abstract available


  138. IVY SP, Kohn EC
    Drug development and registration: Challenges and opportunities in ovarian cancer.
    Cancer. 2017 May 12. doi: 10.1002/cncr.30645.
    PubMed    


    March 2017
  139. SAMIMI G, Minasian LM
    Opportunistic salpingectomy: What about the role of the ovary in ovarian cancer?
    Cancer. 2017 Mar 23. doi: 10.1002/cncr.30525.
    PubMed    


    February 2017
  140. ZANET E, Ciancia R, Michieli M, Tirelli U, et al
    "Twistin' the night away": Fertility preservation in young adult female cancer survivors.
    Cancer. 2017;123:707-708.
    PubMed    


  141. BENEDICT C, Thom B, Friedman DN, Diotallevi D, et al
    Reply to "Twistin' the night away": Fertility preservation in young adult female cancer survivors.
    Cancer. 2017;123:708-709.
    PubMed    


  142. JACKSON SE, Steptoe A, Fisher A
    Reply to Sexual quality of life in the cancer continuum.
    Cancer. 2017;123:530-531.
    PubMed    


    December 2016
  143. GULATI R, Albertsen PC
    Insights from the PLCO trial about prostate cancer screening.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30472.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: